1. Academic Validation
  2. Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions

Glucose consumption of vascular cell types in culture: toward optimization of experimental conditions

  • Am J Physiol Cell Physiol. 2022 Jan 1;322(1):C73-C85. doi: 10.1152/ajpcell.00257.2021.
Keiichi Torimoto 1 Keisuke Okuno 1 Ryohei Kuroda 1 No'Ad Shanas 1 Stephanie M Cicalese 1 Kunie Eguchi 1 Katherine J Elliott 1 Tatsuo Kawai 1 Cali B Corbett 1 Amanda M Peluzzo 1 Amanda K St Paul 1 Michael V Autieri 1 Rosario Scalia 1 Victor Rizzo 1 Tomoki Hashimoto 2 Satoru Eguchi 1
Affiliations

Affiliations

  • 1 Cardiovascular Research Center, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania.
  • 2 Barrow Aneurysm and AVM Research Center, Departments of Neurosurgery and Neurobiology, Barrow Neurological Institute, Phoenix, Arizona.
Abstract

In this study, we have looked for an optimum media glucose concentration and compared glucose consumption in three vascular cell types, endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and adventitial fibroblasts (AFs) with or without angiotensin II (AngII) stimulation. In a subconfluent 6-well experiment in 1 mL DMEM with a standard low (100 mg/dL), a standard high (450 mg/dL), or a mixed middle (275 mg/dL) glucose concentration, steady and significant glucose consumption was observed in all cell types. After 48-h incubation, media that contained low glucose was reduced to almost 0 mg/dL, media that contained high glucose remained significantly higher at ∼275 mg/dL, and media that contained middle glucose remained closer to physiological range. AngII treatment enhanced glucose consumption in AFs and VSMCs but not in ECs. Enhanced extracellular acidification rate by AngII was also observed in AFs. In AFs, AngII induction of target proteins at 48 h varied depending on the glucose concentration used. In low glucose media, induction of glucose regulatory protein 78 or Hexokinase II was highest, whereas induction of VCAM-1 was lowest. Utilization of specific inhibitors further suggests essential roles of angiotensin II type-1 receptor and glycolysis in AngII-induced fibroblast activation. Overall, this study demonstrates a high risk of hypo- or hyperglycemic conditions when standard low or high glucose media is used with vascular cells. Moreover, these conditions may significantly alter experimental outcomes. Media glucose concentration should be monitored during any culture experiments and utilization of middle glucose media is recommended for all vascular cell types.

Keywords

angiotensin II; endothelial cells; fibroblasts; glycolysis; vascular smooth muscle cells.

Figures
Products